ABOUT IPS
IPS-Integrated Project Services is a global provider of technical consulting, architecture, engineering, project controls, construction management, and CGMP compliance services for technically complex pharmaceutical development and manufacturing facilities worldwide.
FEATURED SERVICES
The Cardinal Group, an IPS Company, approaches the inception of every construction project with the “end in mind." We will deliver a fully functional project that supports the science, medicine, or research for its intended design – as our schedule predicted – to enhance successful facility operations. Cardinal delivers on this promise with our intellectual capital as a true knowledge-based firm with tremendous experience in Front-end Planning, Design Management, Trade & Equipment Procurement, Construction, Start-up, Commissioning, and Turnover.
Our internationally recognized team of experts brings to clients an unmatched level of skills, knowledge, and business acumen gained from years of industry experience, including at pharmaceutical companies and equipment suppliers. They have completed over $3 billion in aseptic capital projects and have over 300 years of combined aseptic processing experience.
Our team of design experts collaborate with our clients to envision a facility's strategic future - evaluating its current capacity versus the long-term needs. We interview stakeholders and users, collect, document, and analyze resourcing, building, and process data to build a road map to guide decision making.
Our highly specialized team of process architects - one of the deepest and strongest in the world - work with our clients to design facilities and processes that manufacture the most technically advanced, scientific products in the pharmaceutical and life sciences industries.
IPS is the recognized leader in the design of technically complex product development and manufacturing facilities around the world. Our cross-functional approach to design delivers value throughout the entire design process; from feasibility studies through detailed design and construction assistance.
Our cross functional teams of technical and subject matter experts, many of whom come from industry, have successfully collaborated with clients around the world to produce facility and site master plans identify the gaps between business needs and facility and site assets. Our proven five-step process of: aligning, collecting, analyzing, developing, and recommending achieves an outcome focused on the goals and objectives.
The construction management team delivers comprehensive turnkey construction management services spanning the entire execution process - from pre-design consulting, constructability analysis, through occupancy - across geographic regions, industry sectors, and facility types. We utilize lean construction and project delivery tools and techniques including offsite and modular construction to reduce waste and build value throughout each phase of project delivery, without compromising safety.
Our technical automation and instrumentation experts continuously evaluate and implement automation technologies and systems that move us toward Industry 4.0. Our experts deliver solutions in automation strategies and evaluation, SCADA and control system upgrades, building automation, and technology obsolescence management plans.
Our industry-leading compliance subject matter experts combine their technical and operational expertise in the areas of design, construction, commissioning, qualification, and validation to produce fully operational and compliant commercial operations.
Using our integrated EPCMV process allows us to deliver exceptional manufacturing facilities to the clients we serve. We understand the complex nature of the systems and structures in the facilities we produce. From bioreactors to powder transfer systems, cosmetics to medical devices, we are at the forefront of the latest advances in the industry. Our approach takes a holistic view of each project. We provide the latest, proven concepts to deliver exceptional results for the clients we serve.
Our team has the experience and technical knowledge to execute the most complex, demanding laboratory projects. Our unique approach combines the design elements with operational excellence, energy efficiency and risk and safety assessment as required to meet your specialty lab needs.
At the forefront of the industry, our experts continuously acquire knowledge on the latest technologies, equipment, and methodologies to prepare goods for distribution. The IPS packaging teams tailor solutions to the unique challenges and desires of our clients. Partnerships with our clients are key to a successful project that produces a result specific to the project goals and objectives. Working together, we define a balance between efficiency, flexibility, quality, and cost that is unique to each facility and installation all the while maintaining focus on regulatory requirements.
IPS and GCON have partnered to create iCON, a turnkey modular facility platform solution for the biomanufacturing industry. The collaboration provides the most flexible and rapidly deployable facility platform, meeting the modular and mobile demands of the industry. The iCONteam's broad range of technical capabilities and services along with prefabricated cleanroom PODs provides a true turnkey solution to biopharmaceutical manufacturers and CMOs with needs for production agility and capacity flexing.
We are internationally recognized as experts in advanced aseptic processing and risk-based isolation and barrier technologies. Our experience, awareness and understanding of industry trends places importance on time-to-market, plant flexibility and cost control to avoid costly project delays and minimize risk.
Whether the products are new or existing, our Drug Development and Technology Transfer services offer solutions that consistently maintain quality and compliance to effectively accelerate scale-up through market launch. Our experts provide ideas that speed pharmaceutical and biotech products to market.
Our team has the experience and technical knowledge to execute the most complex, demanding laboratory projects. Our unique approach combines the design elements with operational excellence, energy efficiency and risk and safety assessment as required to meet your laboratory needs.
Knowing the technology, industry trends, regulatory environment and manufacturing processes enables our process/bioprocess engineers to identify opportunities to streamline production and maximize efficiency.
With technical expertise spanning R&D to pilot-scale and large-scale production, our team knows the technology, trends and regulatory environment to successfully deliver any sized project. Our unique approach and technical expertise enables us to significantly improve operational capabilities, throughput and process control, optimize cost and minimize risk.
With biomanufacturing technical expertise spanning R&D to pilot-scale and large-scale production, our team knows the technology, trends and regulatory environment to successfully deliver any sized project. Our unique approach and technical expertise enables us to significantly improve operational capabilities, throughput and process control, optimize cost and minimize risk.
We provide the knowledge, flexibility and technical expertise through our risk-based approach designed to reduce risk, lower costs, improve efficiency and productivity and comply with mandates and requirements. We minimize the impact of operations through energy management programs and our unique solutions to modernize facilities and reduce the environmental footprint.
CONTACT INFORMATION
IPS-Integrated Project Services
721 Arbor Way, Suite 100
Blue Bell, PA 19422
UNITED STATES
Phone: 610.828.4090
Contact: Sales
FEATURED ARTICLES
-
![T Cell attacking cancer cell GettyImages-862601694]( "Scaling Your CAR-T Operation: A Guide For The Life Sciences Leader")
The need to adapt and expand your CAR-T operation efficiently and effectively has never been more critical than it is in the current and rapidly evolving landscape of cellular therapies.
-
![Question Mark GettyImages-1439267750]( "Lab Designs: What Is On The Horizon?")
To keep up with the accelerated pace of research, flexible labs will be necessary for our brilliant scientists to access a changing array of instruments as hypotheses emerge and assessments evolve.
-
![T Cell attacking cancer cell GettyImages-862601694]( "Achieve Flexible, Optimized Manufacturing Capacity For CAR-T Therapies")
Although the fundamental processes and technologies supporting CAR-T production are essentially universal, the diversity of these products can necessitate a closer look at a facility’s overall design.
-
![Patient Waiting GettyImages-1288961992]( "Patients Are Waiting: Commercial CAR-T Facility Design To CQV")
As more CAR-T therapies achieve commercial success, the current scarcity of specialized manufacturing capacity will only serve to stall production scale-up for these crucial modalities.
-
![IPS - New CEO]( "IPS Appoints Jim Stephanou As New CEO")
IPS, a leading provider of architecture, engineering, procurement, construction management, and validation services for the life sciences sector, announces the appointment of Jim Stephanou as its new Chief Executive Officer (CEO) to lead the company into its next phase of growth.
-
![GettyImages-1388184871-quality-compliance-approval]( "From Regulators To PUPSIT: Notes On Annex 1 Revision Implementation")
Kevin Smyth, a biochemical engineer with 30 years of experience in the pharmaceutical industry, offers insights and expertise in working with firms to understand what regulators seek to meet new standards.
-
![Vaccination-vials-GettyImages-1367995665]( "How Agile Construction Can Help Bring New Drugs And Vaccines To Market")
Learn how implementing flexibility in agile construction, adopting predictive data analytics, and referencing benchmarking data can enable contractors to assist swift vaccine rollout and meet demand for new treatments.
-
![Compliance GettyImages-1348548209]( "Annex 1 – The Brave New World Of Regulatory Compliance")
The revision to Annex 1 will become effective in August 2023. Explore the major changes and considerations along with the next steps to achieve Annex 1 Regulatory compliance.
-
![DNA GettyImages-1356994719]( "What Improvements Do We Need To See In Cell And Gene Supply Chains?")
As the cell and gene therapy industry segment grows, the global supply chain faces constraints. Learn about the supply of these life-saving therapies and what improvements are needed.
-
![m_ips-grows-in-ireland-with-new-office-in-cork-32]( "Pharmaceutical Engineering Firm IPS Opens Office In Cork Ireland To Meet Industry Demands")
IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation (EPCMV) services, announces the continued expansion in Ireland with the announcement of a new office in the city of Cork. As Ireland’s presence in the life sciences industry grows, the demand for our design and engineering services grows alongside it.
-
![GettyImages-1335381149- MRNA, Vaccine]( "Review Of mRNA Vaccines & Therapeutics Manufacturing Challenges")
Learn more about the challenges that arise during the synthesis, purification, and encapsulation of mRNA.
-
![GettyImages-1302453801 trial design ps]( "12 Strategies To Accelerate Facility Design And Construction In Drug Manufacturing")
Learn 12 strategies and solutions for accelerating the design and construction process that can yield record breaking delivery times.
-
![Abzena Selects IPS]( "Abzena Selects IPS For Turnkey Delivery Of Their New CGMP Facility In North Carolina")
IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation (EPCMV) services, announces its support to Abzena (North Carolina) LLC to perform full design, construction management, and CQV services for their new monoclonal antibody (mAb) facility in Sanford, North Carolina.
-
![Overcomming challenges cell gene therapy]( "Overcoming The Challenges Of Cell And Gene Therapy Facilities")
Read how inceptioneering, an early-stage planning process, can ease the shift from R&D to manufacturing.
-
![Facility Design Construction iStock-1156760877.jpg]( "Radical Schedule Reduction Design And Construction Strategies For Life Sciences")
Read insights into the challenges, solutions, and key considerations to optimize success when looking to radically reduce design and construction schedules for research lab projects.
-
![GettyImages-1297146235-dna]( "Review Of mRNA Vaccines & Therapeutics Manufacturing Challenges: Plasmid DNA Manufacturing")
This review suggests technical remedial options for the production of pDNA and focus on mRNA synthesis, purification and encapsulation.
-
![Vaccine manufacturing Vials GettyImages-1321403688]( "EPCMV Pioneering In Pandemic Times")
Utilize engineering, procurement, construction management, and validation (EPCMV) for rapid delivery of complex projects with tight deadlines and costs from start to finish on your life science capital projects.
-
The Cardinal Group was awarded the project based on an integrated delivery approach, with IPS as the Engineer of Record. Their combined technical expertise and experience is critical to the success of this aggressive schedule-driven project.
-
IPS designed a new 4x2000L (maximum production scale) multi-product, multi-phase monoclonal antibody and vaccine production facility. The greenfield site was designed to seed, scale up, harvest, and purify cell culture and vaccine products utilizing up to 100% single-use systems. The concept included six manufacturing modules of which four were identical to allow for process flexibility of different unit operations, scales, and phases of material. The other two were designed to accommodate formulation of buffer and/or media as well as other additives.
-
Our client’s objective for the flex fill project was to install a new, independent filling suite for manufacturing specialized sterile injectable products. The new line would increase capacity with a state-of-the-art flexible filling line and associated ancillary support functions. This new capability was important as a CMO. Manufacturing continued throughout the duration of the project.
